New research study explores attitudes to polio immunisation in India

(Medical Xpress) -- The University of Birmingham is working with Ravenshaw University in Orissa on a new research project looking at ethics, policy and practice concerning polio vaccination in the state.

Although encouragingly has been removed from the list of polio endemic countries, misconceptions still remain around polio vaccination within the country. 

This two-year project will gather relevant empirical evidence about attitudes to polio vaccination campaigns in Orissa from three key groups - parents, community workers and those involved in planning and implementing the campaign, such as government officials. While no cases of polio have been officially reported recently in the state, the research team will study more remote tribal areas where facilities are less developed.

The study will outline and systematically explore the ethical issues that arise in relation to vaccination in general, as well as the issues raised by the empirical material gathered as part of the project. The aim is that this project will initiate a longstanding collaboration between the University of Birmingham and Ravenshaw in terms of both teaching and research in ethics and history relating to health.  The first of a series of interdisciplinary research workshops will be held in Bhubaneswar in early December to widen the areas of discussion and seek topics for further joint work in the future.

Angus Dawson, Professor of Public Health Ethics from the College of Medical and Dental Sciences at the University of Birmingham, said:

“A lot of people in India do not opt for mass vaccination programmes for a number of reasons. We want to explore these reasons and bring about an attitudinal change. It's very exciting to be working in Orissa with Ravenshaw University on this kind of project. My background is in philosophy and ethics, but I have to engage with the real world of vaccination policy and practice. We expect to learn a lot about the historical, social and cultural context of public health work, and think this will result in new depth in terms of our own understanding, and further research questions to be explored in the future”.

add to favorites email to friend print save as pdf

Related Stories

India marks 1 year since last polio case

Jan 13, 2012

(AP) -- The top U.S. health official administered polio vaccination drops to children in New Delhi on Friday as India marked one year since its last case of the crippling disease.

Polio outbreak in Tajikistan is cause for alarm

Jun 23, 2010

The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial in CMAJ (Canadian Medical Association Journal). It is imperative th ...

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Perampanel for epilepsy: Still no proof of added benefit

Aug 19, 2014

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

User comments